Growth Metrics

Concentrix (CNXC) Cash & Equivalents (2020 - 2026)

Concentrix's Cash & Equivalents history spans 7 years, with the latest figure at $222.7 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 27.7% to $222.7 million in Q1 2026 year-over-year; TTM through Feb 2026 was $222.7 million, a 27.7% decrease, with the full-year FY2025 number at $327.3 million, up 36.07% from a year prior.
  • Cash & Equivalents hit $222.7 million in Q1 2026 for Concentrix, down from $327.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for CNXC hit a ceiling of $2.1 billion in Q3 2023 and a floor of $142.2 million in Q1 2022.
  • Historically, Cash & Equivalents has averaged $344.6 million across 5 years, with a median of $234.8 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 1099.89% in 2023 and later tumbled 88.35% in 2024.
  • Tracing CNXC's Cash & Equivalents over 5 years: stood at $157.5 million in 2022, then surged by 87.56% to $295.3 million in 2023, then fell by 18.54% to $240.6 million in 2024, then skyrocketed by 36.07% to $327.3 million in 2025, then tumbled by 31.97% to $222.7 million in 2026.
  • Business Quant data shows Cash & Equivalents for CNXC at $222.7 million in Q1 2026, $327.3 million in Q4 2025, and $350.3 million in Q3 2025.